blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3941929

EP3941929 - RECOMBINANT ADENO-ASSOCIATED VIRUS VECTORS [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  24.12.2021
Database last updated on 21.05.2024
FormerThe international publication has been made
Status updated on  28.09.2020
Formerunknown
Status updated on  27.04.2020
Most recent event   Tooltip03.01.2024New entry: Renewal fee paid 
Applicant(s)For all designated states
Ginkgo Bioworks, Inc.
27 Drydock Avenue, 8th floor
Boston, MA 02210 / US
[2023/48]
Former [2022/04]For all designated states
Stridebio, Inc.
P.O. Box 110321
Durham NC 27709 / US
Inventor(s)01 / MCCOY, Daniel
7 Wythebrook Lane
Durham, North Carolina 27713 / US
02 / BERRY, Garrett E.
4812 Swanns Mill Drive
Durham, North Carolina 27704 / US
[N/P]
Former [2022/04]01 / MCCOY, Daniel
Durham, North Carolina 27713 / US
02 / BERRY, Garrett E.
Durham, North Carolina 27704 / US
Representative(s)J A Kemp LLP
80 Turnmill Street
London EC1M 5QU / GB
[N/P]
Former [2022/04]Cooley (UK) LLP
22 Bishopsgate
London EC2N 4BQ / GB
Application number, filing date20719535.520.03.2020
[2022/04]
WO2020US23877
Priority number, dateUS201962821710P21.03.2019         Original published format: US 201962821710 P
[2022/04]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2020191300
Date:24.09.2020
Language:EN
[2020/39]
Type: A1 Application with search report 
No.:EP3941929
Date:26.01.2022
Language:EN
The application published by WIPO in one of the EPO official languages on 24.09.2020 takes the place of the publication of the European patent application.
[2022/04]
Search report(s)International search report - published on:EP24.09.2020
ClassificationIPC:C07K14/005, C12N15/86
[2022/04]
CPC:
C07K14/005 (EP,KR,US); C12N15/86 (EP,KR,US); A61K48/00 (KR,US);
A61P25/00 (KR); C12N2750/14122 (EP,KR,US); C12N2750/14143 (EP,KR,US);
C12N2750/14145 (KR) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2022/04]
TitleGerman:REKOMBINANTE ADENO-ASSOZIIERTE VIRUSVEKTOREN[2022/04]
English:RECOMBINANT ADENO-ASSOCIATED VIRUS VECTORS[2022/04]
French:VECTEURS VIRAUX ADÉNO-ASSOCIÉS RECOMBINANTS[2022/04]
Entry into regional phase29.09.2021National basic fee paid 
29.09.2021Designation fee(s) paid 
29.09.2021Examination fee paid 
Examination procedure29.09.2021Examination requested  [2022/04]
29.09.2021Date on which the examining division has become responsible
12.05.2022Amendment by applicant (claims and/or description)
Fees paidRenewal fee
25.03.2022Renewal fee patent year 03
23.03.2023Renewal fee patent year 04
03.01.2024Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[A]WO2015038958  (CALIFORNIA INST OF TECHN [US]) [A] 1-16,56-73 * abstract * * paragraphs [0009] , [0 11] , [0 55] - [0057] - [ 122] , [ 148] - [0152] - [ 156] * * examples 1, 3, 4, 7, 8 * * sequence 2 *;
 [A]WO2017058892  (UNIV NORTH CAROLINA CHAPEL HILL [US], et al) [A] 1-16,56-73 * abstract * * page 1, lines 15-19 * * page 2, lines 5-32 * * page 18, line 4 - page 52, line 18 * * page 87, line 25 - page 88, line 5 * * page 89, lines 16-24 * * examples 1, 2 * * claims 1-207 * * sequence 9 *;
 [AP]WO2019195444  (STRIDEBIO INC [US]) [AP] 1-16,56-73 * abstract * * paragraphs [0002] , [00 7] - [0015] - [0 67] - [0161] - [ 273] * * claims 1-97 ** sequences 14, 15 *
by applicantUS4501729
 WO9005142
 US4968603
 US5399346
 US5478745
 WO9811244
 US5863541
 US5869248
 US5877022
 US5882652
 US5905040
 US5916563
 WO9961601
 US6013487
 US6040183
 WO0017377
 WO0028061
 WO0028004
 US6083702
 US6093570
 US6156303
 WO0192551
 US2002192189
 US2003017131
 WO03095647
 US2004013645
 WO2006021724
 WO2006029319
 JP2006073052
 WO2006066066
 US7071172
 WO2006119137
 US7201898
 WO2007100465
 US7314912
 WO2008088895
 WO2010093784
 WO2014144229
 WO2017058892
    - COTMORE et al., Archives of Virology, vol. 2
    - GAO et al., J. Virology, (20040000), vol. 78, pages 6381 - 6388
    - MORIS et al., Virology, (20040000), vol. 33, pages 375 - 383
    - "GenBank", Database accession no. NC_001540
    - SRIVISTAVA et al., J. Virology, (19830000), vol. 45, page 555
    - CHIORINI et al., J Virology, (19980000), vol. 71, page 6823
    - CHIORINI et al., J. Virology, (19990000), vol. 73, page 1309
    - BANTEL-SCHAAL et al., J Virology, (19990000), vol. 73, page 3994
    - MURAMATSU et al., Virology, (19960000), vol. 221, page 208
    - SHADE et al., J. Virol., (19860000), vol. 58, page 921
    - GAO et al., Proc. Nat. Acad. Sci. USA, (20020000), vol. 99, page 11854
    - XIE et al., Proc. Nat. Acad. Sci., (20020000), vol. 99, pages 10405 - 10
    - DIMATTIA et al., J. Virol., (20120000), vol. 86, pages 6947 - 6958
    - NAM et al., J. Virol., (20070000), vol. 81, pages 12260 - 12271
    - NG et al., J. Virol., (20100000), vol. 84, pages 12945 - 12957
    - GOVINDASAMY et al., J. Virol., (20130000), vol. 87, pages 11187 - 11199
    - GOVINDASAMY et al., J. Virol., (20060000), vol. 80, pages 11556 - 11570
    - LERCH et al., Virology, (20100000), vol. 403, pages 26 - 36
    - KAILASAN et al., J. Virol., (20150000), vol. 89, pages 2603 - 2614
    - XIE et al., J. Mol. Biol., (19960000), vol. 6, pages 497 - 520
    - TSAO et al., Science, (19910000), vol. 251, pages 1456 - 64
    - MCCARTY, D.M. et al., Gene Therapy, (20010000), vol. 8, pages 1248 - 1254
    - MUZYCZKA, Curr. Topics Microbiol. Immunol., (19920000), vol. 158, page 97
    - CHAO et al., Molecular Therapy, (20000000), vol. 2, page 619
    - ALTSCHUL et al., Methods in Enzymology, (19960000), vol. 266, pages 460 - 480
    - WANG et al., Annu Rev Biophys Biomol Struct., (20060000), vol. 35, pages 225 - 49
    - SMITHWATERMAN, Adv. Appl. Math., (19810000), vol. 2, page 482
    - NEEDLEMANWUNSCH, J Mol. Biol., (19700000), vol. 48, page 443
    - PEARSONLIPMAN, Proc. Natl. Acad. Sci. USA, (19880000), vol. 85, page 2444
    - DEVEREUX et al., Nucl. Acid Res., (19840000), vol. 12, pages 387 - 395
    - ALTSCHUL et al., J Mol. Biol., (19900000), vol. 215, pages 403 - 410
    - KARLIN et al., Proc. Natl. Acad. Sci. USA, (19930000), vol. 90, pages 5873 - 5787
    - ALTSCHUL et al., Nucleic Acids Res., (19970000), vol. 25, pages 3389 - 3402
    - AGBANDJE-MCKENNA et al., Virology, (19940000), vol. 203, pages 106 - 488
    - HAUCK et al., J. Virology, (20030000), vol. 77, pages 2768 - 2774
    - SHI et al., Human Gene Therapy, (20060000), vol. 17, pages 353 - 361
    - GRIFMAN et al., Molecular Therapy, (20010000), vol. 3, pages 964 - 975
    - BROWN et al., Science, (19930000), vol. 262, page 114
    - CHAPMAN et al., Virology, (19930000), vol. 194, page 419
    - CHIPMAN et al., Proc. Nat. Acad. Sci. USA, (19960000), vol. 93, page 7502
    - CLEVES, Current Biology, (19970000), vol. 7, page R318
    - MARGOLSKI, Curr. Top. Microbiol. Immun., (19920000), vol. 158, page 67
    - PALOMBO et al., J. Virology, (19980000), vol. 72, page 5025
    - FERRARI et al., Nature Med., (19970000), vol. 3, page 1295
    - ZHANG et al., Gene Ther., (20010000), vol. 18, pages 704 - 12
    - ZOLOTUKHIN et al., Gene Therapy, (19990000), vol. 6, page 973
    - URABE et al., Human Gene Therapy, (20020000), vol. 13, pages 1935 - 43
    - VINCENT et al., Nature Genetics, (19930000), vol. 5, page 130
    - WANG et al., Proc. Natl. Acad. Sci. USA, (20000000), vol. 97, pages 1 3714 - 13719
    - GREGOREVIC et al., Mol. Ther., (20080000), vol. 16, pages 657 - 64
    - TINSLEY et al., Nature, (19960000), vol. 384, page 349
    - FANG et al., Nature Biotechnology, (20050000), vol. 23, pages 584 - 590
    - PUTTARAJU et al., Nature Biotech., (19990000), vol. 17, page 246
    - SHARP et al., Science, (20000000), vol. 287, page 2431
    - GORMAN et al., Proc. Nat. Acad. Sci. USA, (19980000), vol. 95, page 4929
    - ANDINO et al., J. Gene Med., (20080000), vol. 10, pages 132 - 142
    - LI et al., Acta Pharmacol Sin., (20050000), vol. 26, pages 51 - 55
    - HOSHIJIMA et al., Nat. Med., (20020000), vol. 8, pages 864 - 871
    - MIYAMURA, Proc. Nat. Acad. Sci USA, (19940000), vol. 91, page 8507
    - S.A. ROSENBERG, Immunity, (19910000), vol. 10, page 281
    - KAWAKAMI et al., Proc. Natl. Acad. Sci. USA, (19940000), vol. 91, page 3515
    - KAWAKAMI et al., J. Exp. Med., (19940000), vol. 180, page 347
    - KAWAKAMI et al., Cancer Res., (19940000), vol. 54, page 3124
    - BRICHARD et al., J Exp. Med., (19930000), vol. 178, page 489
    - LEVINE, Ann. Rev. Biochem., (19930000), vol. 62, page 623
    - ROSENBERG, Ann. Rev. Med., (19960000), vol. 47, pages 481 - 91
    - "Immunophysiology: Cell Function and Cellular Interactions in Antibody Formation", HERBERT B. HERSCOWITZ, IMMUNOLOGY: BASIC PROCESSES, (19850000), vol. 117
    - ARRUDA et al., Blood, (20050000), vol. 105, pages 3458 - 3464
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.